20Mar2015 NASH is the Next Monster Pharmaceutical Market. Here Are The Players /Luke Timmerman/4/All, Drugs, Strategy20 Mar 2015 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.